COP29 outcomes fall short on climate health action

Agreements made at COP29 fell short of the ambition and focus needed to fully address the impacts of climate change on health and maximize the benefits of action, according to experts from the London School of Hygiene & Tropical Medicine (LSHTM).

Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its

October 10, 2023

Q&A: American Heart Association president on GLP1-s and ‘common ground’ with the next White House

CHICAGO — In his presidential address to the American Heart Association on Sunday, Keith Churchwell, a clinical cardiologist and past hospital administrator, started right at

November 18, 2024

FDA Rejects Full Approval of Liver Disease Drug

The FDA declined to grant full approval to obeticholic acid (Ocaliva) for treating primary biliary cholangitis (PBC), Intercept Pharmaceuticals announced on Tuesday. The decision follows

November 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.